Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study
Dimopoulos, Meletios, MD, Siegel, David S, MD, Lonial, Sagar, MD, Qi, Junyuan, MD, Hajek, Roman, MD, Facon, Thierry, MD, Rosinol, Laura, MD, Williams, Catherine, MD, Blacklock, Hilary, MD, Goldschmidt, Hartmut, MD, Hungria, Vania, MD, Spencer, Andrew, MD, Palumbo, Antonio, MD, Graef, Thorsten, MD, Eid, Joseph E, MD, Houp, Jennifer, PharmD, Sun, Linda, PhD, Vuocolo, Scott, PhD, Anderson, Kenneth C, MD
Published in The lancet oncology (01.10.2013)
Published in The lancet oncology (01.10.2013)
Get full text
Journal Article
Monoclonal Gammopathy of Undetermined Significance: Predictors of Malignant Transformation and Recognition of an Evolving Type Characterized by a Progressive Increase in M Protein Size
Rosiñol, Laura, MD, Cibeira, M. Teresa, MD, Montoto, Silvia, MD, Rozman, María, MD, Esteve, Jordi, MD, Filella, Xavier, MD, Bladé, Joan, MD
Published in Mayo Clinic proceedings (01.04.2007)
Published in Mayo Clinic proceedings (01.04.2007)
Get full text
Journal Article